Stability indicating UPLC method for simultaneous determination of atorvastatin, fenofibrate and their degradation products in tablets

Journal of Pharmaceutical and Biomedical Analysis

Volumn 48, Issue 1, 2008, Pages 120-126

  Kadav, A A ^a   Vora, D N ^a  

^a INSTITUTE OF SCIENCE   (India)

Author keywords

Atorvastatin; Fenofibrate; Impurities; Stability indicating method; UPLC

Indexed keywords

ATORVASTATIN; FENOFIBRATE; FIBATOR; UNCLASSIFIED DRUG;

ACCURACY; ARTICLE; DRUG DEGRADATION; DRUG DETERMINATION; DRUG FORMULATION; DRUG PURITY; DRUG STABILITY; DRUG STRUCTURE; INDIA; LIQUID CHROMATOGRAPHY; PRIORITY JOURNAL; QUALITY CONTROL; TABLET; TABLET FORMULATION; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY;

ANTICHOLESTEREMIC AGENTS; BUFFERS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG CONTAMINATION; DRUG STABILITY; HEPTANOIC ACIDS; HYDROGEN-ION CONCENTRATION; MOLECULAR STRUCTURE; PROCETOFEN; PYRROLES; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TABLETS; TIME FACTORS;

EID: 49749121450     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2008.05.018     Document Type: Article

References (28)

1. http://www.rxlist.com/cgi/generic/atorvastatin.htm.
2. http://www.rxlist.com/cgi/generic/antara.htm.
3. The United States Pharmacopoeia, 30th ed., The United States Pharmacopeial Convention Inc., 2007.
4. The British Pharmacopoeia, British Pharmacopoeial Commission, London, 2007.
5. United states patent application publication No. US2007/0014846 A1, January 18, 2007.
6. Athyros V., Papageorgiou A., Athyrou V., Demitriadis D., and Kontopoulos A. Diabetes Care 25 (2002) 1198-1202
7. Malik J., Melenovsky V., Wichterle D., Haas T., Simek J., Ceska R., and Hradec J. Cardiovasc. Res. 52 (2001) 290-298
8. Bullen W., Miller R., and Hayes R. J. Am. Soc. Mass Spectrom. 10 (1999) 55-56
9. Jemal M., Ouyang Z., Chen B., and Teitz D. Rapid Commun. Mass Spectrom. 13 (1999) 1003-1015
10. Miao X., and Metcalfe C. J. Chromatogr. A 998 (2003) 133-141
11. Erturk S., Aktas E., Ersoy L., and Ficicioglu S. J. Pharm. Biomed. Anal. 33 (2003) 1017-1023
12. Altuntas T., and Erk N. J. Liq. Chromatogr. Relat. Technol. 27 (2004) 83-93
13. Erk N. Crit. Rev. Anal. Chem. 34 (2004) 1-7
14. Shen H., Li Z., Shi X., and Zong M. Zongguo Yiyao Gongye Zazhi 36 (2004) 223-225
15. Rajeswari K., Rao P., Sankar G., Rao A., Raju D., Rao J., and Seshagiri L. Int. J. Chem. Sci. 4 (2006) 167-170
16. Gowari S., Raju M., Sumanth K., and Latha P. Asian J. Chem. 17 (2005) 2571-2574
17. Erk N. Anal. Lett. 36 (2003) 2699-2711
18. Yadav S., Mhaske D., Kakad A., Patil B., Kadam S., and Dhaneshwar S. Indian J. Pharm. Sci. 67 (2005) 182-188
19. El-Gindy A., Emara S., Mesbah M., and Hadad G. Farmaco 60 (2005) 425-438
20. Yardimci C., and Ozaltin N. Anal. Bioanal. Chem. 378 (2004) 495-498
21. Ji X., and Ye C. Zhongguo Yaoke Daxue Xucbao 18 (1987) 284-286
22. Lacroix P., Dawson B., Sears R., Black D., Cyr T., and Ethier J. J. Pharm. Biomed. Anal. 18 (1998) 383-402
23. Fan G., Lin M., Zhang Z., and An D. Yaowu Fenxi Zazhi 20 (2000) 231-234
24. Cotta-Ramusino A., and Carozzi A. J. Chromatogr. Biomed. Appl. 56 (1986) 419-424
25. Nagaraj V.K., and Rajshree M. Anal. Sci. 23 (2007) 445-451
26. Wren S., and Tchelitcheff P. J. Chromatogr. A 1119 (2006) 140-146
27. Novakova L., Matysova L., and Solich P. Talanta 68 (2006) 908-918
28. International Conference on Harmonization (ICH), Q2 (R1), Validation of analytical procedures: text and methodology, 2005.